NFSG
Newbridge Financial Services Group’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $545K | Sell |
6,567
-2,379
| -27% | -$197K | 0.09% | 173 |
|
|
2025
Q1 | $725K | Sell |
8,946
-1,639
| -15% | -$133K | 0.18% | 99 |
|
|
2024
Q4 | $953K | Sell |
10,585
-1,419
| -12% | -$128K | 0.24% | 76 |
|
|
2024
Q3 | $1.19M | Sell |
12,004
-596
| -5% | -$58.9K | 0.42% | 59 |
|
|
2024
Q2 | $1.17M | Buy |
12,600
+419
| +3% | +$38.8K | 0.44% | 49 |
|
|
2024
Q1 | $1.16M | Buy |
12,181
+44
| +0.4% | +$4.18K | 0.5% | 42 |
|
|
2023
Q4 | $1.08M | Buy |
12,137
+1,302
| +12% | +$116K | 0.53% | 33 |
|
|
2023
Q3 | $791K | Sell |
10,835
-1,229
| -10% | -$89.7K | 0.4% | 46 |
|
|
2023
Q2 | $1M | Sell |
12,064
-143
| -1% | -$11.9K | 0.49% | 31 |
|
|
2023
Q1 | $930K | Sell |
12,207
-885
| -7% | -$67.4K | 0.49% | 34 |
|
|
2022
Q4 | $1.09M | Sell |
13,092
-528
| -4% | -$43.8K | 0.63% | 24 |
|
|
2022
Q3 | $1.08M | Buy |
13,620
+5,876
| +76% | +$466K | 0.63% | 17 |
|
|
2022
Q2 | $575K | Buy |
7,744
+1,570
| +25% | +$117K | 0.36% | 68 |
|
|
2022
Q1 | $555K | Buy |
6,174
+3,174
| +106% | +$285K | 0.27% | 72 |
|
|
2021
Q4 | $336K | Sell |
3,000
-1,314
| -30% | -$147K | 0.16% | 135 |
|
|
2021
Q3 | $542K | Buy |
4,314
+319
| +8% | +$40.1K | 0.34% | 64 |
|
|
2021
Q2 | $541K | Buy |
3,995
+599
| +18% | +$81.1K | 0.33% | 65 |
|
|
2021
Q1 | $461K | Sell |
3,396
-15
| -0.4% | -$2.04K | 0.34% | 64 |
|
|
2020
Q4 | $480K | Sell |
3,411
-621
| -15% | -$87.4K | 0.4% | 54 |
|
|
2020
Q3 | $449K | Buy |
+4,032
| New | +$449K | 0.44% | 50 |
|